他汀依从性与房颤及非房颤患者复发性卒中风险降低相关
本研究在21家医院整合医疗系统中,分析6116例出院时使用他汀的缺血性卒中患者,其中23.6%有房颤。结果显示,较高他汀依从率(平均85%)与无房颤(HR 0.78)和有房颤(HR 0.59)患者3年复发性缺血性卒中风险降低均相关,且房颤患者服用华法林时调整INR治疗范围时间后关联仍稳健(HR 0.61)。
要点
- 他汀依从性越高,无房颤和有房颤患者的复发性缺血性卒中风险均降低。
- 房颤患者他汀依从性与卒中风险降低的关联强度不亚于无房颤患者。
- 房颤状态不应成为排除他汀用于二级卒中预防的理由。
核心结论
- 他汀依从性与复发性卒中风险降低的关联在房颤患者中与无房颤患者同样强,房颤不应成为排除他汀二级预防的理由。
研究设计与样本
- 在21家医院整合医疗系统中,对5年内出院时使用他汀的6116例缺血性卒中患者进行观察性研究。
- 其中1446例(23.6%)出院时诊断有房颤。
- 他汀依从性以覆盖天数百分比衡量,平均依从率为85。
主要发现
- 较高他汀依从性预测无房颤患者复发性缺血性卒中风险降低(HR 0.78;95%CI 0.63-0.97)。
- 较高他汀依从性预测有房颤患者复发性缺血性卒中风险降低(HR 0.59;95%CI 0.43-0.81)。
- 在服用华法林的房颤患者中,调整INR治疗范围时间后关联仍稳健(HR 0.61;95%CI 0.41-0.89)。
- 较高覆盖天数百分比与更大程度低密度脂蛋白抑制相关。
临床怎么用
- 对于缺血性卒中患者,无论是否合并房颤,均应鼓励坚持他汀治疗以降低复发风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Outpatient statin use reduces the risk of recurrent ischemic stroke among patients with stroke of atherothrombotic cause. It is not known whether statins have similar effects in ischemic stroke caused by atrial fibrillation (AFib). METHODS: We studied outpatient statin adherence, measured by percentage of days covered, and the risk of recurrent ischemic stroke in patients with or without AFib in a 21-hospital integrated healthcare delivery system. RESULTS: Among 6116 patients with ischemic stroke discharged on a statin over a 5-year period, 1446 (23.6%) had a diagnosis of AFib at discharge. The mean statin adherence rate (percentage of days covered) was 85, and higher levels of percentage of days covered correlated with greater degrees of low-density lipoprotein suppression. In multivariable survival models of recurrent ischemic stroke over 3 years, after controlling for age, sex, race/ethnicity, medical comorbidities, and hospital center, higher statin adherence predicted reduced stroke risk both in patients without AFib (hazard ratio, 0.78; 95% confidence interval, 0.63-0.97) and in patients with AFib (hazard ratio, 0.59; 95% confidence interval, 0.43-0.81). This association was robust to adjustment for the time in the therapeutic range for international normalized ratio among AFib subjects taking warfarin (hazard ratio, 0.61; 95% confidence interval, 0.41-0.89). CONCLUSIONS: The relationship between statin adherence and reduced recurrent stroke risk is as strong among patients with AFib as it is among patients without AFib, suggesting that AFib status should not be a reason to exclude patients from secondary stroke prevention with a statin.
引用
- Flint AC, Conell C, Ren X, et al. Statin Adherence Is Associated With Reduced Recurrent Stroke Risk in Patients With or Without Atrial Fibrillation. Stroke. 2017. PMID: 28596457. doi:10.1161/STROKEAHA.117.017343
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。